Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy-Reference-Cited by-同舟云学术

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy

Published:2023-06-14 Issue:7 Volume:13 Page:1603-1610
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Di Gregorio Carlo,Tretti-Clementoni Matteo,Belmontesi Magda,Romagnoli Marina,Innocenti Alessandro,Zanchi Malvina,Leone Lucia,Damiani Giovanni^ORCID,Iozzo Ivano

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-023-00951-x.pdf

Reference12 articles.

1. Flynn TC. Advances in the use of botulinum neurotoxins in facial esthetics. J Cosmet Dermatol. 2012;11:42–50.

2. Li X, Sui C, Xia X, Chen X. Efficacy and safety of botulinum toxin type A for treatment of glabellar lines: a network meta-analysis of randomized controlled trials. Aesthetic Plast Surg. 2022. https://doi.org/10.1007/s00266-022-03018-y.

3. Anido J, Arenas D, Arruabarrena C, et al. Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone. Clin Cosmet Investig Dermatol. 2017;10:413–21.

4. Hilton S, Kestemont P, Sattler G, et al. Liquid abobotulinumtoxinA: pooled data from two double-blind, randomized, placebo-controlled phase III studies of glabellar line treatment. Dermatol Surg. 2022;48(11):1198–202.

5. Ascher B, Kestemont P, Boineau D, et al. Liquid formulation of abobotulinumtoxinA exhibits a favorable efficacy and safety profile in moderate to severe glabellar lines: a randomized, double-blind, placebo- and active comparator-controlled trial. Aesthet Surg J. 2018;38(2):183–91.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ready‐to‐use abobotulinumtoxinA solution versus powder botulinumtoxinA for treatment of glabellar lines: Investigators' and subjects' experience in a Phase IV study;Journal of Cosmetic Dermatology;2024-05-28

2. Real-World Patient Experience With PrabotulinumtoxinA in the United Kingdom: A Single-Center Survey and Analysis of 254 Patients;Aesthetic Surgery Journal Open Forum;2024